Adrenal gland- Upk1b negative adrenocortical adenoma.
Adrenal gland- Upk1b negative adrenocortical adenoma. 
Breast- Upk1b negative invasive breast cancer of no special type (NST).
Breast- Upk1b negative invasive breast cancer of no special type (NST). 
Colon- Upk1b negative colorectal adenocarcinoma.
Colon- Upk1b negative colorectal adenocarcinoma. 
Esophagus- Adenocarcinoma showing a moderate to strong Upk1b immunostaining of tumor cells.
Esophagus- Adenocarcinoma showing a moderate to strong Upk1b immunostaining of tumor cells. 
Esophagus- Squamous cell carcinoma showing a strong Upk1b positivity in most tumor cells.
Esophagus- Squamous cell carcinoma showing a strong Upk1b positivity in most tumor cells. 
Kidney- Papillary renal cell carcinoma with moderate to strong Upk1b immunostaining of tumor cells.
Kidney- Papillary renal cell carcinoma with moderate to strong Upk1b immunostaining of tumor cells. 
Kidney- Upk1b negative clear cell renal cell carcinoma.
Kidney- Upk1b negative clear cell renal cell carcinoma. 
Lung- Malignant mesothelioma (epitheloid) with strong Upk1b immunostaining of all tumor cells.
Lung- Malignant mesothelioma (epitheloid) with strong Upk1b immunostaining of all tumor cells. 
Lung- Squamous cell carcinoma with strong Upk1b positivity in the majority of tumor cells.
Lung- Squamous cell carcinoma with strong Upk1b positivity in the majority of tumor cells. 
Lung- Strong Upk1b immunostaining of all tumor cells in an epitheloid malignant mesothelioma.
Lung- Strong Upk1b immunostaining of all tumor cells in an epitheloid malignant mesothelioma. 
Lung- Upk1b negative adenocarcinoma.
Lung- Upk1b negative adenocarcinoma. 
Lung- Upk1b negative small cell carcinoma.
Lung- Upk1b negative small cell carcinoma. 
Ovary- Endometroid carcinoma with strong Upk1b immunostaining of tumor cells.
Ovary- Endometroid carcinoma with strong Upk1b immunostaining of tumor cells. 
Ovary- Serous high-grade carcinoma with a moderate to strong Upk1b immunostaining of the majority of tumor cells.
Ovary- Serous high-grade carcinoma with a moderate to strong Upk1b immunostaining of the majority of tumor cells. 
Pancreas- Upk1b negative neuroendocrine tumor.
Pancreas- Upk1b negative neuroendocrine tumor. 
Penis- Upk1b negative squamous cell carcinoma.
Penis- Upk1b negative squamous cell carcinoma. 
Prostate- Upk1b negative adenocarcinoma (Gleason 3+3=6).
Prostate- Upk1b negative adenocarcinoma (Gleason 3+3=6). 
Salivary gland- Warthin tumor with strong Upk1b immunostaining of a fraction of tumor cells.
Salivary gland- Warthin tumor with strong Upk1b immunostaining of a fraction of tumor cells. 
Skin- Upk1b negative basal cell carcinoma.
Skin- Upk1b negative basal cell carcinoma. 
Skin- Upk1b negative squamous cell carcinoma.
Skin- Upk1b negative squamous cell carcinoma. 
Soft tissue- Upk1b negative liposarcoma.
Soft tissue- Upk1b negative liposarcoma. 
Stomach- Upk1b negative gastric adenocarcinoma.
Stomach- Upk1b negative gastric adenocarcinoma. 
Stomach- Upk1b negative gastrointestinal stromal tumor (GIST).
Stomach- Upk1b negative gastrointestinal stromal tumor (GIST). 
Testis- Upk1b negative seminoma.
Testis- Upk1b negative seminoma. 
Testis- Upk1b negative yolk sack tumor.
Testis- Upk1b negative yolk sack tumor. 
Thyroid- Upk1b negative papillary carcinoma.
Thyroid- Upk1b negative papillary carcinoma. 
Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) with strong Upk1b immunostaining of tumor cells.
Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) with strong Upk1b immunostaining of tumor cells. 
Urinary bladder- Upk1b negative sarcomatoid urothelial carcinoma.
Urinary bladder- Upk1b negative sarcomatoid urothelial carcinoma.